Parlar, A. Et Al. 2017. Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy. European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress , (Berlin, Germany).

Parlar, A., Pamukcu, C., Ozkazanc, D., Aras, M., Dahlberg, C., Chrobok, M., ... Zahedimaram, P.(2017). Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy . European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Germany

Parlar, A. Et Al. "Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy," European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Germany, 2017

Parlar, A. Et Al. "Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy." European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress , Berlin, Germany, 2017

Parlar, A. Et Al. (2017) . "Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy." European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress , Berlin, Germany.

@conferencepaper{conferencepaper, author={A. Parlar Et Al. }, title={Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy}, congress name={European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress}, city={Berlin}, country={Germany}, year={2017}}